SOURCE: Leerink Swann & Company

June 23, 2005 08:19 ET

Leerink Swann & Company Initiates Coverage of ViaCell, Inc. (NASDAQ: VIAC)

BOSTON, MA -- (MARKET WIRE) -- June 23, 2005 -- This morning, Senior Biotechnology Analyst, William Tanner, Ph.D., initiated coverage of ViaCell, Inc. with an Outperform rating. His investment rating is based on his belief that ViaCell has developed a proprietary technology platform that should permit the expansion of stem cells beyond past scale-up limitations and that this technology could aid the commercialization of human cellular therapies. ViaCell's retention of significant commercialization rights especially for use of stem cells to treat Type I diabetes and cardiac insufficiency also contributes to his Outperform rating.

About ViaCell, Inc.

ViaCell, Inc. (NASDAQ: VIAC) is a clinical-stage biotechnology company dedicated to enabling the application of human cells as medicine. The company is developing a pipeline of proprietary products to address cancer, cardiac disease, diabetes and infertility. Its lead cord blood derived stem cell therapy candidate, CB001, is currently in a Phase I clinical trial. ViaCell is headquartered in Cambridge, Massachusetts.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564